GE HealthCare Technologies Inc.
GEHC
Rang in aandelen
#773
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Aandeelprijs
$69.86
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$31.56B
Verandering (1 dag)
0.15%
Verandering (1 jaar)
-8.19%
Land
US
Handel GE HealthCare Technologies Inc. (GEHC)
Categorie
Healthcare
Aantal uitstaande aandelen voor GE HealthCare Technologies Inc. (GEHC)
Aantal uitstaande aandelen per June 2026: 453.00M
Volgens de laatste financiële rapporten en de aandelenkoers van GE HealthCare Technologies Inc. bedraagt het huidige aantal uitstaande aandelen 453.00M. Aan het einde van December 2024 had het bedrijf 456.00M uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van GE HealthCare Technologies Inc. (GEHC) van 2019 tot 2026
Uitstaande aandelen aan het einde van elk jaar
| Jaar | Uitstaande aandelen | Wijzigen |
|---|---|---|
| 2026 (TTM) | 453.00M | -0.77% |
| 2025 | 456.52M | 0.11% |
| 2024 | 456.00M | 0.22% |
| 2023 | 455.00M | 0.24% |
| 2022 | 453.93M | -0.17% |
| 2021 | 454.71M | 0.00% |
| 2020 | 454.71M | 0.00% |
| 2019 | 454.71M | 0.00% |
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Uitstaande aandelen | Verschil | Land |
|---|---|---|---|
| 104.47M | -76.94% |
AU
|
|
| 205.38M | -54.66% |
US
|
|
| 179.92M | -60.28% |
US
|
|
| 129.98M | -71.31% |
US
|
|
| - | - |
US
|
